Dr. Uboha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-266-6020
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015- Yale-New Haven Medical CenterResidency, Internal Medicine, 2007 - 2010
Yale School of MedicineClass of 2007
Certifications & Licensure
WI State Medical License 2015 - 2025
CT State Medical License 2010 - 2015- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs Start of enrollment: 2017 Aug 22
- Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer Start of enrollment: 2018 May 29
- Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 Start of enrollment: 2019 Aug 26
- Join now to see all
Publications & Presentations
PubMed
- 269 citationsNeuroendocrine and adrenal tumors, version 2.2021Manisha H. Shah, Whitney S. Goldner, Al B. Benson, Emily K. Bergsland, Lawrence S. Blaszkowsky
Journal of the National Comprehensive Cancer Network. 2021-07-28 - 61 citationsImmunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, Thierry Alcindor, Angela N Bartley
Journal of Clinical Oncology. 2023-03-01 - 22 citationsPraluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, Alexander Spira, Funda Meric-Bernstam
Clinical Cancer Research. 2022-05-13
Lectures
- Phase I dose-escalation trial of trifluridine/tipiracil (TAS-102) and temozolomide in the treatment of advanced neuroendocrine tumors.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Phase II study of the combination of abemaciclib and pembrolizumab in locally advanced unresectable or metastatic gastroesophageal adenocarcinoma: Big Ten Cancer Resea...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
Press Mentions
Clinical Scenarios and Approaches to Treating Locally Advanced Esophageal AdenocarcinomaAugust 28th, 2024- Bispecific Antibodies in Gastric Cancer: Big Questions but Bigger Potential?August 26th, 2024
- Chemotherapy-Immunotherapy Combination Shows Efficacy in Esophagogastric Cancer SubsetJuly 12th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
